Tokugawa M, Inoue Y, Aoki H, Miyajima C, Ishiuchi K, Tsurumi K, Kujirai C, Morishita D, Matsuno M, Mizukami H, Ri M, Iida S, Makino T, Aoyama M, Hayashi H.
J Biochem, 2024, 175, 253-263.
Takeshita S, Kakita H, Nakamura N, Mori M, Toriuchi K, Aoki H, Inoue Y, Hayashi H, Yamada Y, Aoyama M.
Exp Neurol, 2024, 377, 114781.
Yamamura A, Fujiwara M, Kawade A, Amano T, Hossain A, Nayeem MJ, Kondo R, Suzuki Y, Inoue Y, Hayashi H, Suzuki S, Sato M, Yamamura H.
Eur J Pharmacol, 2024, 973, 176564.
Chem Commun, 2024, 60, 968-971.
Hypothermia Attenuates Neurotoxic Microglial Activation via TRPV4.
Fukuda N, Toriuchi K, Mimoto R, Aoki H, Kakita H, Suzuki Y, Takeshita S, Tamura T, Yamamura H, Inoue Y, Hayashi H, Yamada Y, Aoyama M.
Neurochem Res, 2024, 49, 800-813.
Nagasaka M, Inoue Y, Nagao Y, Miyajima C, Morishita D, Aoki H, Aoyama M, Imamura T, Hayashi H.
Sci Rep, 2023, 13, 22877.
Sunakawa Y, Kondo M, Yamamoto Y, Inomata T, Inoue Y, Mori D, Mizuno T.
ACS Appl Bio Mater, 2023, 6, 5493-5501.
Owaki R, Aoki H, Toriuchi K, Inoue Y, Hayashi H, Takeshita S, Kakita H, Yamada Y, Aoyama M.
Exp Cell Res, 2023, 432, 113784.
The DNMT3B Inhibitor Nanaomycin A as a Neuroblastoma Therapeutic Agent.
Izumi K, Aoki H, Kakita H, Takeshita S, Ueda H, Inoue Y, Hayashi H, Yamada Y, Aoyama M.
Curr Cancer Drug Targets, 2023, 23, 837-842.
Monocyte-Derived miRNA-1914-5p Attenuates IL-1β-Induced Monocyte Adhesion and Transmigration.
Toriuchi K, Kihara T, Aoki H, Kakita H, Takeshita S, Ueda H, Inoue Y, Hayashi H, Shimono Y, Yamada Y, Aoyama M.
Int J Mol Sci, 2023, 24, 2829.
The Combination of ATM and Chk1 Inhibitors Induces Synthetic Lethality in Colorectal Cancer Cells.
Tozaki Y, Aoki H, Kato R, Toriuchi K, Arame S, Inoue Y, Hayashi H, Kubota E, Kataoka H, Aoyama M.
Cancers, 2023, 15, 735.
Nagasaka M, Miyajima C, Aoki H, Aoyama M, Morishita D, Inoue Y, Hayashi H.
Cells, 2022, 11, 3825.
Miyajima C, Hayakawa Y, Inoue Y, Nagasaka M, Hayashi H.
Pharmaceuticals, 2022, 15, 1015.
Nagasaka M, Inoue Y, Yoshida M, Miyajima C, Morishita D, Tokugawa M, Nakamoto H, Sugano M, Ohoka N Hayashi
H.
FEBS Lett., 2022, 596, 465-478.
Periplocin and cardiac glycosides suppress the unfolded protein response.
Tokugawa M, Inoue Y, Ishiuchi K, Kujirai C, Matsuno M, Ri M, Itoh Y, Miyajima C, Morishita D, Ohoka N, Iida S, Mizukami H, Makino T, Hayashi H.
Sci. Rep., 2021, 11, 9528.
Anti-Inflammatory Activity of Kurarinone Involves Induction of HO-1 via the KEAP1/Nrf2 Pathway.
Nishikawa S, Inoue Y, Hori Y, Miyajima C, Morishita D, Ohoka N, Hida S, Makino T, Hayashi H.
Antioxidants, 2020, 9, 842.
Miyajima C, Kawarada Y, Inoue Y, Suzuki C, Mitamura K, Morishita D, Ohoka N, Imamura T, Hayashi H.
Cells, 2020, 9, 171.
A novel negative regulatory mechanism of Smurf2 in BMP/Smad signaling in bone.
Kushioka J, Kaito T, Okada R, Ishiguro H, Bai Z, Kodama J, Chijimatsu R, Pye M, Narimatsu M, Wrana JL, Inoue Y, Ninomiya H, Yamamoto S, Saitou H, Yoshikawa H, Imamura T.
Bone Res., 2020, 8, 41.
Sumito N, Koeda S, Umezawa N, Inoue Y, Tsukiji S, Higuchi T, Mizuno T.
Bioconjug. Chem., 2020, 31, 821-833.
Fukuura K, Inoue Y, Miyajima C, Watanabe S, Tokugawa M, Morishita D, Ohoka N, Komada M, Hayashi H.
J. Biol. Chem., 2019, 294, 16429-16439.
Nisjikawa S, Itoh Y, Tokugawa M, Inoue Y, Nakashima KI, Hori Y, Miyajima C, Yoshida K, Morishita D, Ohoka N, Inoue M, Mizukami H, Makino T, Hayashi H.
Molecules, 2019, 24, 3110.
Sakai S, Ohhata T, Kitagawa K, Uchida C, Aoshima T, Niida H, Suzuki T, Inoue Y, Miyazawa K, Kitagawa M.
Cancer Res., 2019, 79, 2821-2838.
TRB1 negatively regulates gluconeogenesis by suppressing the transcriptional activity of FOXO1.
Tsuzuki K, Itoh Y, Inoue Y, Hayashi H.
FEBS Lett., 2019, 593, 369-380.
Lysine-Specific Demethylase 1 (LSD1/KDM1A) Is a Novel Target Gene of
c-Myc.
Nagasaka M, Tsuzuki K, Ozeki Y, Tokugawa M, Ohoka N, Inoue Y, Hayashi H.
Biol. Pharm. Bull., 2019, 42, 481-488.
Ieda N, Itoh K, Inoue Y, Izumiya Y, Kawaguchi M, Miyata N, Nakagawa H.
Bioorg. Med. Chem. Lett., 2019, 29, 353-356.
Nagasaka M, Hashimoto R, Inoue Y, Ishiuchi K, Matsuno M, Itoh Y, Tokugawa M, Ohoka N, Morishita D, Mizukami H, Makino T, Hayashi H.
Molecules, 2018, 23, 1394.
Inoue Y, Kawachi S, Ohkubo T, Nagasaka M, Ito S, Fukuura K, Itoh Y, Ohoka N, Morishita D, Hayashi H.
FEBS Lett., 2017, 591, 3682-3691.
TGF-β induces p53/Smads complex formation in the PAI-1 promoter to activate transcription.
Kawarada Y, Inoue Y, Kawasaki F, Fukuura K, Sato K, Tanaka T, Itoh Y, Hayashi H.
Sci. Rep., 2016, 6, 35483.
Nakashima K, Tanabe H, Fujii-Kuriyama Y, Hayashi H, Inoue M.
J. Nat. Med., 2016, 70, 476-482.
Inoue Y, Itoh Y, Sato K, Kawasaki F, Sumita C, Tanaka T, Morishita D, Hayashi H.
Curr. Cancer Drug Targets, 2016, 16, 110-118.
Sakai S, Miyajima C, Uchida C, Itoh Y, Hayashi H, Inoue Y.
Curr. Cancer Drug Targets, 2016, 16, 147-156.
Positive Regulation of Interleukin-2 Expression by a Pseudokinase, Tribbles 1, in Activated T Cells.
Miyajima C, Itoh Y, Inoue Y, Hayashi H.
Biol. Pharm. Bull., 2015, 38, 1126-1133.
Miyajima C, Inoue Y, Hayashi H.
Biol. Pharm. Bull., 2015, 38, 618-624.
Inoue Y, Abe K, Onozaki K, Hayashi H.
Biol. Pharm. Bull., 2015, 38, 536-544.
Sakai Y, Fukamachi K, Futakuchi M, Miyoshi I, Tsuda H, Suzui M, Hayashi H.
Biol. Pharm. Bull., 2014, 37, 1068-1074.
The NADPH oxidase inhibitor diphenyleneiodonium activates the human TRPA1 nociceptor.
Suzuki H, Hatano N, Muraki Y, Itoh Y, Kimura S, Hayashi H, Onozaki K, Ohi Y, Haji A, Muraki K.
Am. J. Physiol. Cell Physiol., 2014, 307, C384-394.
TRPV4 partially participates in proliferation of human brain capillary endothelial cells.
Hatano N, Suzuki H, Itoh Y, Muraki K.
Life Sci., 2013, 92, 317-324.
Itoh S, Yamaoka N, Kamoshida G, Takii T, Tsuji T, Hayashi H, Onozaki K.
Biochem. Biophys. Res. Commun., 2013, 433, 127-132.
Sakai Y, Fukamachi K, Futakuchi M, Hayashi H, Suzui M.
Oncol. Rep., 2013, 30, 64-70.
The roles of TGF-β signaling in carcinogenesis and breast cancer metastasis.
Imamura T, Hikita A, Inoue Y.
Breast Cancer, 2012, 19, 118-124.
Dan S, Okamura M, Mukai Y, Yoshimi H, Inoue Y, Hanyu A, Sakaue-Sawano A, Imamura T, Miyawaki A, Yamori T.
Eur. J. Cancer, 2012, 48, 936-943.
Hatano N, Itoh Y, Suzuki H, Muraki Y, Hayashi H, Onozaki K, Wood IC, Beech DJ, Muraki K.
J. Biol. Chem., 2012, 287, 31962-31972.
Xu J, Itoh Y, Hayashi H, Takii T, Miyazawa K, Onozaki K.
Biol. Pharm. Bull., 2011, 34, 1724-1730.
Suppression of p53 activity through the cooperative action of Ski and histone deacetylase SIRT1.
Inoue Y, Iemura S, Natsume T, Miyazawa K, Imamura T.
J. Biol. Chem., 2011, 286, 6311-6320.
Cigarette smoke condensate extracts augment collagen-induced arthritis in mice.
Chujo S, Okamoto S, Sunahara R, Adachi M, Yamada K, Hayashi H, Takii T, Hayakawa K, Onozaki K.
Int. Immunopharmacol., 2010, 10, 1194-1199.
Dual mode of regulation of cell division cycle 25 A protein by TRB3.
Sakai S, Ohoka N, Onozaki K, Kitagawa M, Nakanishi M, Hayashi H.
Biol. Pharm. Bull., 2010, 33, 1112-1116.
Fukasawa H, Yamamoto T, Fujigaki Y, Misaki T, Ohashi N, Takayama T, Suzuki S, Mugiya S, Oda T, Uchida C, Kitagawa K, Hattori T, Hayashi H, Ozono S, Kitagawa M, Hishida A.
Int. J. Cancer, 2010, 127, 1517-1525.
Arakawa T, Hayashi H, Itoh S, Takii T, Onozaki K.
Biochem. Biophys. Res. Commun., 2010, 392, 369-372.
Anaphase-promoting complex/cyclosome-cdh1 mediates the ubiquitination and degradation of TRB3.
Ohoka N, Sakai S, Onozaki K, Nakanishi M, Hayashi H.
Biochem. Biophys. Res. Commun., 2010, 392, 289-294.
Kido S, Kuriwaka-Kido R, Umino-Miyatani Y, Endo I, Inoue D, Taniguchi H, Inoue Y, Imamura T, Matsumoto T.
PLoS One, 2010, 5, e13090.
SKI and MEL1 cooperate to inhibit transforming growth factor-beta signal in gastric cancer cells.
Takahata M, Inoue Y, Tsuda H, Imoto I, Koinuma D, Hayashi M, Ichikura T, Yamori T, Nakasaki K, Yoshida M, Matsuoka M, Morishita K, Yuki K,
Hanyu A, Inazawa J, Miyazono K, Imamura T.
Cardiac fibroblasts have functional TRPV4 activated by 4alpha-phorbol 12,13-didecanoate.
Hatano N, Itoh Y, Muraki K.
Life Sci., 2009, 85, 808-814.
An environmental sensor, TRPV4 is a novel regulator of intracellular Ca2+ in human synoviocytes.
Itoh Y, Hatano N, Hayashi H, Onozaki K, Miyazawa K, Muraki K.
Am. J. Physiol. Cell Physiol., 2009, 297, C1082-1090.
Two mechanistically and temporally distinct NF-kappaB activation pathways in IL-1 signaling.
Yamazaki K, Gohda J, Kanayama A, Miyamoto Y, Sakurai H, Yamamoto M, Akira S, Hayashi H, Su B, Inoue J.
Sci. Signal., 2009, 2, ra66.
Ishikawa F, Akimoto T, Yamamoto H, Araki Y, Yoshie T, Mori K, Hayashi H, Nose K, Shibanuma M.
J. Biochem., 2009, 146, 123-132.
Ohoka N, Kato S, Takahashi Y, Hayashi H, Sato R.
Mol. Endocrinol., 2009, 23, 759-771.
Fukunaga E, Komiya S, Horiguchi K, Goto K, Saitoh M, Miyazawa K, Koinuma D, Hanyu A, Imamura T.
Regulation of TGF-beta family signaling by E3 ubiquitin ligases.
Inoue Y, Imamura T.
Arima Y, Inoue Y, Shibata T, Hayashi H, Nagano O, Saya H, Taya Y.
Cancer Res., 2008, 68, 5104-5112.
Shizu M, Itoh Y, Sunahara R, Chujo S, Hayashi H, Ide Y, Takii T, Koshiko M, Chung SW, Hayakawa K, Miyazawa K, Hirose K, Onozaki K.
J. Interferon Cytokine Res., 2008, 28, 509-521.
Takahashi Y, Ohoka N, Hayashi H, Sato R.
J. Lipid Res., 2008, 49, 880-92.
Arakawa T, Yamamura T, Hattori T, Hayashi H, Mori A, Yoshida A, Uchida C, Kitagawa M, Onozaki K.
Int. Immunopharmacol., 2008, 8, 80-89.
Enya K, Hayashi H, Takii T, Ohoka N, Kanata S, Okamoto T, Onozaki K.
J. Leukoc. Biol., 2008, 83, 190-199.
Inoue Y, Kitagawa M, Taya Y.
EMBO J., 2007, 26, 2083-2093.
Smad3 is acetylated by p300/CBP to regulate its transactivation activity.
Inoue Y, Itoh Y, Abe K, Okamoto T, Daitoku H, Fukamizu A, Onozaki K, Hayashi H.
Oncogene, 2007, 26, 500-508.
Ohoka N, Hattori T, Kitagawa M, Onozaki K, Hayashi H.
J. Biol. Chem., 2007, 282, 35687-35694.
Ohoka N, Yoshii S, Hattori T, Onozaki K, Hayashi H.
EMBO J., 2005, 24, 1243-1255.
Hayashi H, Abdollah S, Qiu Y, Cai J, Xu YY, Grinnell BW, Richardson MA, Topper JN, Gimbrone MA Jr, Wrana JL, Falb D.
Cell, 1997, 89, 1165-1173.